The team is currently testing small molecule inhibitors of LSF as a possible therapy for HCC in animal models.

This advancement represents a breakthrough in the management of this complex disease, and proves that molecular targeted therapies can be effective in this otherwise chemo-resistant tumor.

International Digest: Most HCC is not diagnosed until the disease is at an advanced stage. What novel molecular markers are there for the early diagnosis for HCC?